Medications for Prostatic Neoplasms

47 results
  • Novadoz Pharmaceuticals LLC
    Usage: Abiraterone acetate tablets are indicated, in combination with prednisone, for treating metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC).
  • MSN LABORATORIES PRIVATE LIMITED
    Usage: Abiraterone acetate tablets are indicated, in combination with prednisone, for the treatment of metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC).
  • Apotex Corp.
    Usage: Abiraterone acetate, in combination with prednisone, is indicated for treating metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC).
  • Apotex Corp.
    Usage: Abiraterone acetate tablets are indicated for use with prednisone in treating metastatic castration-resistant prostate cancer (CRPC) and metastatic high-risk castration-sensitive prostate cancer (CSPC).
  • AvKARE
    Usage: Abiraterone acetate tablets, in combination with prednisone, are indicated for the treatment of metastatic castration-resistant prostate cancer (CRPC).
  • VistaPharm, LLC
    Usage: Aminocaproic acid is indicated for enhancing hemostasis in bleeding due to fibrinolysis, particularly in life-threatening situations. It is used in cases involving surgical complications, hematological disorders, abruptio placentae, hepatic cirrhosis, neoplastic diseases, and excessive urinary tract bleeding related to surgeries or conditions affecting the genitourinary system.
  • Seton Pharmaceuticals, LLC
    Usage: Aminocaproic acid tablets enhance hemostasis in cases where fibrinolysis causes bleeding, particularly after heart surgery, in hematological disorders, abruptio placentae, hepatic cirrhosis, and certain cancers. It also addresses excessive urinary bleeding following surgical or nonsurgical procedures in the genitourinary system.
  • Carnegie Pharmaceuticals, LLC
    Usage: Aminocaproic acid enhances hemostasis in cases of fibrinolysis-related bleeding, particularly during heart surgery, in hematological disorders, and during severe conditions like abruptio placentae and certain cancers. It also addresses excessive urinary tract bleeding associated with surgical or nonsurgical hematuria.
  • PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
    Usage: Aminocaproic acid is indicated for enhancing hemostasis in cases of bleeding due to fibrinolysis, especially following heart surgeries, in hematological disorders, abruptio placentae, hepatic cirrhosis, and certain cancers. It also addresses excessive urinary tract bleeding related to surgical or nonsurgical hematuria.
  • airis PHARMA Private Limited
    Usage: Aminocaproic acid oral solution is indicated for enhancing hemostasis in cases of fibrinolytic bleeding, particularly post-heart surgery, in hematological disorders, during acute abruptio placentae, in hepatic cirrhosis, and certain cancers. It can also address excessive urinary tract bleeding linked to surgical or nonsurgical hematuria.